跳至主要内容
临床试验/EUCTR2012-002935-27-NL
EUCTR2012-002935-27-NL进行中(未招募)1 期

Diagnostic value of novel MR imaging techniques for the primary staging and restaging of rectal cancer

Maastricht University Medical Center0 个研究点开始时间: 2012年12月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Biopsy proven primary rectal cancer (=15 cm from the anorectal verge as measured on MRI)
  • -Age >18 years
  • -Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 250
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 200

排除标准

  • -Ineligibility to undergo MRI (claustrophobia, pacemaker, non-MR compatible surgical implants, metal fragments in the eye)
  • -Pregnancy
  • -Locally recurrent rectal cancer
  • -A history of severe allergy to contrast agents
  • -Ineligibility to receive gadofosveset contrast (history of contrast allergy, impaired kidney function with a Glomerular Filtration Rate <30 ml/min/1.73m2
  • -Incurable disease due to metastases or co-morbidity

研究者

相似试验